Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
A simple blood test detects over 30 types of cancers
The availability of advanced SLED dialysis for critical patients, Plasmapheresis, CRRT machines along with ICCU dialysis complete the centre in every way
Company expects strong organic growth in sales, EBITDA in 2022
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
Subscribe To Our Newsletter & Stay Updated